PMVP FY 2020 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$84M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$318,000

Operating Income

-$35M

Net Income

-$34M

EPS (Diluted)

$-2.40

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$366M

Total Liabilities

$6M

Stockholders' Equity

$359M

Cash & Equivalents

$361M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$318,000	-$388,000	+18.0%
Operating Income	-$35M	-$27M	-31.2%
Net Income	-$34M	-$25M	-35.8%